Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Regeneus Ltd. ( (AU:CMB) ).
Cambium Bio Limited has announced a proposed issue of 4,570,667 ordinary fully paid securities, with a planned issue date of August 28, 2025. This move is part of a placement or other type of issue and is subject to the ASX’s agreement to quote the securities. The announcement indicates Cambium Bio’s strategic efforts to potentially enhance its market position and operational capabilities through this securities issuance.
More about Regeneus Ltd.
Average Trading Volume: 10,479
Technical Sentiment Signal: Sell
Current Market Cap: A$5.85M
For a thorough assessment of CMB stock, go to TipRanks’ Stock Analysis page.